Project Details
Description
A Randomized, Double Blind MultiCenter Study of Denosumab Compared with Zoledronic Acid ( Zometa) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/13 → 7/28/15 |
Funding
- AMGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.